Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist

Semaglutide and Tirzepatide are highly effective medications for managing obesity and supporting weight loss. They work by mimicking natural hormones—GLP-1, and in the case of Tirzepatide, both GLP-1 and GIP—that help regulate appetite, blood sugar, and metabolism.

Benefits

• Significant weight loss

• Improved blood sugar control

• Enhanced insulin sensitivity

• Reduced cardiovascular risk (Semaglutide)

• Greater weight loss and glucose control with dual-action (Tirzepatide)

Potential Side Effects

• Nausea, vomiting, diarrhea, or constipation (most common when starting treatment)

• Possible increased risk of pancreatitis

• FDA boxed warning for thyroid tumors (seen in animal studies, not humans)

Safety Considerations

These medications may not be appropriate for people with a history of:

• Pancreatitis

• Certain thyroid cancers (including medullary thyroid carcinoma)

Before starting therapy, it’s important to discuss your medical history and goals with a qualified provider to determine if GLP-1 or GIP medications are the right fit for you.